000			03706cam a2200481 i 4500
001			19134394
003			BD-SySUS
005			20230829143642.0
008			160613t20172017ne a b 001 0 eng c
010			_a 2016944588
016	7		_a101701102 _2DNLM
020			_a9780128023020 _qElectronic bk
020			_a0128023023 _qpaperback
040			_aNLM _beng _cNLM _erda _dYDXCP _dBDX _dTKN _dOCLCF _dBTCTA _dOCLCO _dNLM _dOCLCO _dDLC
050	0	0	_aQR189 _b.H862 2017
060	0	0	_a2017 B-458
060	1	0	_aQW 805
082			_a614.473
130	0		_aHuman vaccines (Modjarrad) _963516
245	1	0	_aHuman vaccines : _bemerging technologies in design and development / _cedited by Kayvon Modjarrad, MD, PhD, Associate Director, Emerging Infectious Disease Threats, Military HIV Research Program/Walter Reed Army Institute of Research, Bethesda, MD, USA, Wayne C. Koff, PhD, President and CEO, Human Vaccines Project, New York, NY, USA.
264		1	_aAmsterdam : _bElsevier/Academic Press, _c[2017]
300			_axvii, 191 pages : _billustrations (some color) ; _c23 cm
336			_atext _btxt _2rdacontent
337			_aunmediated _bn _2rdamedia
338			_avolume _bnc _2rdacarrier
504			_aIncludes bibliographical references and index.
505	0		_aPart I. Designing vaccines from a new starting point : Broadly neutralizing antibodies / L. Morris and T.A. Moody -- part II. Pathogen free vaccines : Replication-competent viral vectors for vaccines delivery / C.L. Parks ; Reverse vaccinology: exploiting genomes for vaccines design / E. Del Tordello, R. Rappuoli and I. Delany ; Virus-like particle and nanoparticle vaccines / M. Kanekiyo and C.B. Buck -- part III. Immune monitoring : Systems vaccinology / M. Rolland and M.A. Eller ; Immunogenetics and vaccination / M. John, S. Gaudieri and S. Mallal -- part IV. Advanced vaccine development : Methodical considerations / P.B. Gilbert and R. Gottardo ; Vaccine development in special populations / K.M. Edwards and C.B. Creech.
520			_a"Human Vaccines: Emerging Technologies in Design and Development discusses the advances in molecular biology, biophysics, and informatics-among other disciplines-that have provided scientists with the tools to create new vaccines against emerging and re-emerging pathogens. For example, the virus-like particle technologies that led to licensing of highly efficacious HPV vaccines have only come into full realization in the last 10 years. Their success has, in turn, accelerated the pace with which nanoparticle vaccines are being developed Given the rapidity with which the field is changing and the absence of any text documenting this change, there is a need for a resource that surveys these new vaccine technologies, assesses their potential, and describes their applications. This book provides that resource and complements traditional vaccinology books, but also serves as an excellent standalone for researchers and students with basic knowledge in immunology."-- _cProvided by publisher.
530			_aAlso issued online.
650		0	_aVaccines _xBiotechnology. _963517
650		0	_aVaccines _xDesign. _963518
650		0	_aVaccination. _963519
650	1	2	_aVaccines. _963520
650	2	2	_aDrug Discovery _xtrends. _963521
650	2	2	_aTechnology, Pharmaceutical _xtrends. _963522
650		7	_aVaccination. _2fast _0(OCoLC)fst01163544 _963523
650		7	_aVaccines _xBiotechnology. _2fast _0(OCoLC)fst01163574 _963524
650		7	_aVaccines _xDesign. _2fast _0(OCoLC)fst01163576 _963525
700	1		_aModjarrad, Kayvon, _eeditor. _963526
700	1		_aKoff, Wayne C., _eeditor. _963527
856	4		_uhttp://www.sciencedirect.com/science/book/9780128023020 _3ELSEVIER
942			_2ddc _cEBK
999			_c84994 _d84994